Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer

PURPOSE: The objective of this multicenter phase II study was to evaluate the efficacy and safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancer. MATERIALS AND METHODS: Patients were treated with irinotecan 65 mg/m(2) and cisplatin 30 mg/m(2) on da...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Res Treat
Autori principali: Kim, Miso, Keam, Bhumsuk, Kim, Tae-Min, Kim, Hoon-Gu, Kim, Jin-Soo, Lee, Sung Sook, Shin, Seong Hoon, Kim, Min Kyoung, Park, Keon Uk, Kim, Dong-Wan, Yun, Hwan Jung, Lee, Jong Seok, Heo, Dae Seog
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398400/
https://ncbi.nlm.nih.gov/pubmed/27488873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.121
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi